Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Pacific Edge's Enterprise Value is A$282.42 Mil.
Pacific Edge's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was A$-33.81 Mil. Therefore, Pacific Edge's EV-to-EBIT ratio for today is -8.35.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Pacific Edge's Enterprise Value is A$282.42 Mil.
Pacific Edge's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was A$-32.03 Mil. Therefore, Pacific Edge's EV-to-EBITDA ratio for today is -8.82.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Pacific Edge's Enterprise Value is A$282.42 Mil.
Pacific Edge's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was A$9.93 Mil. Therefore, Pacific Edge's EV-to-Revenue ratio for today is 28.44.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Pacific Edge's Enterprise Value is A$282.42 Mil.
Pacific Edge's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was A$-27.84 Mil. Therefore, Pacific Edge's EV-to-FCF ratio for today is -10.14.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Pacific Edge (ASX:PEB) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Pacific Edge's current Enterprise Value is A$282.42 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Pacific Edge's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was A$-33.81 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Pacific Edge's current Enterprise Value is A$282.42 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Pacific Edge's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was A$-32.03 Mil.
Pacific Edge's current Enterprise Value is A$282.42 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Pacific Edge's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was A$9.93 Mil.
Pacific Edge's current Enterprise Value is A$282.42 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Pacific Edge's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was A$-27.73 Mil.
Pacific Edge's current Enterprise Value is A$282.42 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Pacific Edge's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was A$-27.84 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pacific Edge Enterprise Value Related Terms
Pacific Edge Enterprise Value Historical Data
* Premium members only.
The historical data trend for Pacific Edge's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:PEB vs TMO, DHR, IDXX: Enterprise Value Comparison
For the Diagnostics & Research subindustry, Pacific Edge's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pacific Edge Enterprise Value vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Pacific Edge's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Pacific Edge's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Pacific Edge's Enterprise Value for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of A$282.42 Mil mean?
Pacific Edge (ASX:PEB) has a Enterprise Value of A$282.42 Mil as of Jun. 28, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Pacific Edge and its competitors.
Is Pacific Edge's Enterprise Value too high?
Pacific Edge's current Enterprise Value is A$282.42 Mil. Overall, Pacific Edge has a GF Score™ of 42/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pacific Edge's Enterprise Value compare to TMO and DHR?
Pacific Edge's Enterprise Value of A$282.42 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Diagnostics & Research company?
A good Enterprise Value depends on the Medical Diagnostics & Research industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Pacific Edge and its competitors. Pacific Edge's current Enterprise Value is A$282.42 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pacific Edge stock overvalued right now?
Based on GuruFocus' analysis, Pacific Edge (ASX:PEB) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.05, compared to a current price of A$0.24 — trading 380% above its estimated fair value. The current Enterprise Value is A$282.42 Mil. Pacific Edge's overall GF Score™ is 42/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Pacific Edge (ASX:PEB), the current Enterprise Value is A$282.42 Mil as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pacific Edge (ASX:PEB) Overvalued in 2026?
Based on GuruFocus' analysis, Pacific Edge stock appears to be overvalued.
The current stock price of A$0.24 is trading 380% above its estimated GF Value™ of A$0.05.
GuruFocus considers Pacific Edge to be Significantly Overvalued.
Key valuation signals for ASX:PEB:
Enterprise Value: A$282.42 Mil
GF Value™: A$0.05 vs. price of A$0.24 (380% above fair value)
No single metric tells the full story. See the ASX:PEB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pacific Edge Ltd is a New Zealand-based company involved in researching, developing, and commercialising new diagnostic and prognostic tools for the early detection and management of cancers. It manages and operates the laboratories used for the detection of bladder cancer. It operates in two segments: Commercial, which includes sales, marketing, laboratory, and support operations to run the commercial businesses internationally; and Research, which is into research and development of diagnostic and prognostic products for human cancer. The commercial segment contributes to the majority of the revenue. Pacific Edge has a product in the marketplace called Cxbladder. Its geographical segments are the United States, which generates maximum revenue, New Zealand, and the Rest of the World.
42GF Score
Get the complete analysis for ASX:PEB
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:PEB has been successfully added to your 
